Blockchain Registration Transaction Record

NeuroOne to Showcase OneRF Platform at Oppenheimer MedTech Conference

NeuroOne Medical Technologies to present at Oppenheimer Healthcare Conference on March 17, 2026, featuring updates on its OneRF platform for brain treatment and pain management.

This news matters because NeuroOne's participation in a major healthcare investment conference highlights the growing importance of innovative neurological treatments. The company's OneRF platform and other FDA-cleared technologies represent significant advancements in minimally invasive brain surgery and pain management, potentially reducing hospital stays and improving patient outcomes. For investors, this signals NeuroOne's strategic efforts to secure funding and partnerships to scale its solutions, which could accelerate access to better neurological care. For patients and healthcare providers, it underscores progress toward more effective, cost-efficient treatments for conditions like epilepsy, chronic pain, and other neurological disorders, addressing a critical need in global healthcare.